CONDITIONS • WESTMINSTER, ARVADA, BROOMFIELD, THORTON & DENVER METRO
Psoriasis Treatment in Westminster, CO
Hashimoto's is the most common autoimmune condition in the world — and one of the most poorly managed, because Psoriasis is not a skin condition. It is an immune condition that happens to be visible on the skin. Treating it only at the surface — with creams, phototherapy, or immune-suppressing medications — manages the appearance while the systemic immune dysfunction that produces the plaques continues unaddressed. treatment is directed at the thyroid hormone level rather than at the immune system that is destroying the thyroid.
Psoriasis affects around 3 percent of the global population and is associated with a significantly elevated risk of psoriatic arthritis, cardiovascular disease, metabolic syndrome, and depression. It is one of the most visible and most misunderstood autoimmune conditions — and one of the most responsive to comprehensive naturopathic care when its root drivers are properly identified and treated.
Same-Day & Same-Week Appointments Available
WE UNDERSTAND WHAT YOU'RE GOING THROUGH
Psoriasis is not only physically uncomfortable. It is present in every interaction, every piece of clothing you choose, every time you decide whether to wear short sleeves or roll them down.
The raised, scaly plaques that itch, crack, and sometimes bleed. The embarrassment that is inseparable from a condition that is always visible. The fear of being judged or misunderstood by people who do not know it is not contagious. The unpredictability of flares — triggered by stress, by illness, by a medication change, by a food choice, by nothing at all that you can identify. The periods of relative clearance followed by sudden return. You may have spent years cycling through topical treatments: corticosteroid creams, vitamin D analogues, coal tar preparations, moisturizers, phototherapy sessions. Each has helped to a degree. None has produced the lasting clearance you are looking for. You may have been offered a biologic medication — one of the new immune-blocking drugs that can produce dramatic clearance — and found either that the side effect profile gave you pause, or that you want to understand whether there is more you can do with your own biology before committing to long-term immune suppression. The answer to that question is almost always yes. There is more. And it starts with understanding psoriasis as the whole-body immune condition it actually is.
HOW PSORIASIS PRESENTS
-
Raised, red or pink plaques covered with silvery-white scale, most commonly on the elbows, knees, scalp, and lower back
-
Itching, burning, or soreness at the plaque sites
-
Cracking and bleeding at sites of thick plaque, particularly on the palms and soles
-
Nail changes: pitting, thickening, or separation from the nail bed
-
Scalp involvement: scaling and flaking that extends beyond the hairline
-
Joint pain and swelling — psoriatic arthritis, which affects up to 30 percent of people with psoriasis
-
Flares clearly triggered or worsened by stress, illness, certain medications, or dietary factors
PSORIASIS AS A SYSTEMIC DISEASE
Psoriasis carries a significantly elevated risk of cardiovascular disease, metabolic syndrome, type 2 diabetes, non-alcoholic fatty liver disease, and depression. These are not coincidental associations. They are the systemic consequences of the same chronic immune activation driving the skin. The inflammatory cytokines produced in psoriatic plaques circulate throughout the body, damaging blood vessel walls, promoting insulin resistance, and sustaining the neuroinflammation that underlies mood disorders.
Treating psoriasis comprehensively is cardiovascular treatment, metabolic treatment, and mental health treatment — because the immune fire producing the plaques is burning throughout the entire body, not just at the skin.
WHAT YOU PROBABLY HAVEN'T BEEN TOLD
Psoriatic plaques are the visible end product of an immune process that begins in the gut. The most important interventions for psoriasis are not applied to the skin. They are applied to the immune system — and the gut is where most of that work happens.
WHAT IS ACTUALLY HAPPENING IN PSORIASIS — AND WHAT THE SKIN IS TRYING TO SHOW YOU
In healthy skin, cells at the base of the epidermis divide, mature, travel to the surface, and shed — a process that normally takes about 28 to 30 days. In psoriasis, this process is dramatically accelerated. Skin cells turn over in 3 to 5 days instead of 28, piling up on the surface faster than they can be shed and forming the characteristic thick plaques. This accelerated turnover is driven by immune cells — specifically T helper 17 cells and the inflammatory cytokine interleukin-17 — that have been activated in the skin and are continuously signaling the skin cells to divide. The T cells arrived because the immune system classified something in the body as a threat and sent them to the site. What triggered that classification, and why it targeted the skin, is the question that standard dermatological care almost never investigates.
The gut microbiome is the primary regulator of systemic immune balance. Research has consistently identified significant gut dysbiosis in psoriasis patients — reduced diversity, reduced levels of anti-inflammatory bacterial species, and elevated levels of pro-inflammatory species. This dysbiotic gut produces a persistent low-grade immune activation that primes the Th17 pathway and sustains the inflammatory state that drives psoriatic skin turnover. Intestinal permeability allows bacterial compounds and incompletely digested food proteins to enter the bloodstream and reach immune tissue, sustaining the activation cycle. Restoring the gut microbiome and repairing intestinal permeability reduces the primary upstream driver of the immune activation that produces the plaques — and it does so in a way that topical treatments, phototherapy, and even biologics cannot replicate, because they address the downstream consequence rather than the upstream cause.
The psoriasis-gut connection and the evidence for dietary intervention
Multiple dietary patterns have documented associations with psoriasis severity, and the connections are mechanistically coherent. Gluten sensitivity — both celiac disease and non-celiac gluten sensitivity — is significantly more prevalent in psoriasis patients than in the general population. Gluten triggers intestinal permeability and systemic immune activation through mechanisms that directly feed the Th17-dominant inflammatory pattern of psoriasis. A Mediterranean dietary pattern, rich in anti-inflammatory omega-3s, polyphenols, and fiber, reduces psoriasis severity in multiple studies through its effects on gut microbiome composition and systemic inflammation. Alcohol consumption is one of the most reliably documented psoriasis triggers — it worsens gut permeability, disrupts the microbiome, and stimulates keratinocyte (skin cell) proliferation directly. For patients willing to engage with dietary modification, these are not minor lifestyle suggestions. They are meaningful clinical interventions with documented effect sizes.
Gluten elimination in psoriasis patients with confirmed gluten sensitivity has produced significant plaque improvement in multiple studies — through a gut-immune mechanism, not a skin-direct one.
Vitamin D — the nutrient that is both deficient and therapeutic in psoriasis
Vitamin D holds a unique position in psoriasis care: topical vitamin D analogues are first-line dermatological treatments, applied directly to plaques to slow skin cell proliferation and reduce local inflammation. Yet systemic vitamin D deficiency is extremely prevalent in psoriasis patients, and low serum vitamin D is associated with more severe disease and greater cardiovascular co-morbidity risk. Systemic vitamin D — taken orally — works through entirely different mechanisms than topical application. It regulates the Th17 immune pathway systemically, reduces intestinal permeability, supports regulatory T cells that keep autoimmune inflammation in check, and improves the gut microbiome environment that underlies the immune activation. Correcting systemic vitamin D deficiency in psoriasis is not the same as using topical vitamin D analogues, and the two approaches are genuinely complementary rather than redundant.
Studies have demonstrated that psoriasis patients with higher serum vitamin D levels have significantly lower disease severity scores and reduced cardiovascular risk markers compared to those with deficiency.
Stress, the HPA axis, and psoriasis flares
Stress is one of the most consistently identified and most clinically significant psoriasis triggers. The mechanism is well understood. Chronic stress elevates cortisol and activates the sympathetic nervous system. This shifts the immune system toward the pro-inflammatory Th17 pattern that drives psoriatic inflammation. Stress also directly stimulates neuropeptide release at nerve endings in the skin — substance P in particular — which activates keratinocytes and triggers mast cells in the skin to produce inflammatory mediators that drive plaque formation locally. The result is that stress produces psoriasis flares through both systemic immune and local skin nerve pathways simultaneously. For patients whose psoriasis clearly worsens with stress, this is not a psychological observation — it is a neurological and immunological one. Addressing it through constitutional hydrotherapy, autonomic nervous system regulation, and HPA axis support is treating a direct biological mechanism of their disease.
Patients with psoriasis who address the stress-immune pathway alongside other treatments consistently show greater and more durable improvement than those who focus on skin treatment alone.
OUR APPROACH
Conventional care versus our approach
Standard dermatological care for psoriasis is well-developed and we support it fully, particularly for moderate to severe disease where systemic medications or biologics are appropriate and genuinely effective. Our naturopathic approach provides the upstream gut health, nutritional, and immune modulation work that dermatology does not offer — reducing the inflammatory immune burden that is generating the plaques in the first place.
The conventional approach
What most patients experience
-
Clinical diagnosis based on the characteristic appearance of plaques; occasionally biopsy for atypical presentations
-
Topical corticosteroids and vitamin D analogues for mild to moderate disease
-
Phototherapy (UVB or PUVA) for moderate disease
-
Systemic medications (methotrexate, cyclosporine, acitretin) or biologic agents targeting specific cytokines for moderate to severe disease
-
General advice to avoid triggers such as stress, alcohol, and smoking
-
Gut health, microbiome, gluten sensitivity, vitamin D, HPA axis, and systemic inflammatory drivers not assessed or treated as part of psoriasis management
Standard psoriasis care targets the downstream immune activation in the skin. Its limitation is that the upstream immune drivers — the gut environment, the nutritional picture, the systemic inflammatory burden — are never addressed, meaning treatment manages the plaques without ever reducing the autoimmune fire generating them.
What we do differently
-
Comprehensive immune environment assessment: gut microbiome health, intestinal permeability markers, gluten sensitivity testing, vitamin D, inflammatory markers, and metabolic co-morbidity screening
-
Gut microbiome restoration and intestinal permeability repair: removing the primary upstream immune activation source through targeted probiotics, prebiotics, L-glutamine, and zinc carnosine — rebuilding the gut environment that immune tolerance depends on
-
Dietary anti-inflammatory optimization: Mediterranean pattern as the evidence-based foundation; gluten elimination where sensitivity is identified; omega-3 enrichment for anti-inflammatory prostaglandin balance; alcohol reduction guidance grounded in the well-documented gut-immune mechanism
-
Vitamin D systemic optimization: correcting deficiency to support Th17 immune regulation, regulatory T cell function, and gut integrity — complementary to, not competing with, any topical vitamin D treatment the dermatologist has prescribed
-
HPA axis and autonomic regulation: constitutional hydrotherapy and stress management to directly address the cortisol and neuropeptide pathway that drives stress-triggered flares — treating the stress-psoriasis connection through its actual biological mechanism
-
Cardiovascular and metabolic co-morbidity management: addressing the insulin resistance, lipid dysregulation, and vascular inflammation that progress alongside psoriasis and that standard dermatology does not have the scope to manage
We work alongside the patient's dermatologist. Our approach and dermatological treatment are complementary — the naturopathic work reduces the immune burden the medications are working against, often allowing better results from the same treatment or the possibility of reducing medication burden over time.
WHAT MAKES OUR APPROACH DIFFERENT — IN A SINGLE PARAGRAPH
Standard psoriasis care suppresses the immune activation in the skin. Our approach investigates and addresses why the immune system is activated in the first place — the gut dysbiosis producing the systemic immune priming, the intestinal permeability allowing inflammatory compounds to enter the bloodstream, the gluten sensitivity sustaining immune cross-reactivity, the vitamin D deficiency impairing immune regulatory control, and the chronic stress activating the neuropeptide pathways that drive plaque formation locally. When these upstream drivers are reduced, the immune fire producing the plaques diminishes at its source rather than being suppressed at the surface. For patients also managing psoriatic arthritis, cardiovascular risk, or metabolic dysfunction alongside their skin disease, this systemic immune work is simultaneously the most important intervention for all of their conditions — because all of them share the same autoimmune and inflammatory root.
PSORIASIS AND THE REST OF YOUR HEALTH
Up to 30 percent of people with psoriasis develop psoriatic arthritis. The same immune process driving the skin plaques is attacking the joints — and the earlier both are treated comprehensively, the better the long-term joint and skin outcome.
At True Health Centers, we treat patients with psoriasis, psoriatic arthritis, or both — understanding that these are expressions of the same systemic autoimmune condition and that the structural and immune work benefit from being integrated rather than divided between separate providers who never communicate.
Psoriatic arthritis and joint protection
Psoriatic arthritis can develop in psoriasis patients at any time — sometimes before the skin disease is prominent, sometimes decades after. The joint inflammation is driven by the same Th17 pathway as the skin disease and responds to the same systemic immune modulation approaches that improve skin outcomes. Chiropractic care addresses the joint mechanics directly, reducing the loading stress on inflamed psoriatic joints. Naturopathic immune modulation reduces the systemic inflammatory driver. Both are needed. Neither alone is sufficient for the best possible outcome.
Cardiovascular risk and psoriasis
People with moderate to severe psoriasis have a cardiovascular risk profile comparable to that of diabetic patients — driven by the same systemic inflammatory cytokines that produce the plaques damaging the arterial endothelium and promoting the arterial plaque formation of atherosclerosis. Managing psoriasis comprehensively is cardiovascular risk management. The anti-inflammatory dietary, gut health, and stress reduction work that improves skin outcomes simultaneously reduces the vascular inflammatory burden driving cardiovascular co-morbidity.
The mental health burden of psoriasis
Depression affects up to 30 percent of psoriasis patients — driven both by the psychosocial impact of a visible, stigmatized condition and by the neuroinflammation that the systemic immune activation produces directly. The gut dysbiosis underlying psoriasis reduces serotonin synthesis. The chronic inflammatory cytokines produced in the skin and gut drive neuroinflammatory changes in the brain. Treating the gut and immune picture is therefore simultaneously a mood intervention. Many patients find that as their psoriasis improves through comprehensive treatment, their mood, energy, and cognitive function improve in parallel — because the systemic inflammation driving all three is being addressed at its source.
TAKE THE NEXT STEP
The plaques are on your skin. The cause is in your gut and your immune system. We treat the cause.
Gut microbiome restoration, intestinal permeability repair, vitamin D optimization, anti-inflammatory nutrition, and integrated joint and pain care — alongside your dermatologist.
Not sure where to begin? Give us a call and we'll help you choose the best first step.